Mobile

A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s dis...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-004854-19

A randomized, double-blind, placebo-controlled, parallel group multicenter study to investigate efficacy and safety of ITF 2357 in the management of patients with active moderate to severe Crohn’s disease

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To identify one or more effective doses of ITF 2357 in the management of Crohn’s disease suitable for further evaluation in phase III studies

Critère d'inclusion

  • Crohn’s Disease

Liens